Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL
Conditions: B-cell Acute Lymphoblastic Leukemia Interventions: Drug: CD19-CAR_Lenti_ALLO Sponsors: Bambino Ges ù Hospital and Research Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Hospitals | Leukemia | Pediatrics | Research